BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22167411)

  • 21. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas.
    Meza-Zepeda LA; Kresse SH; Barragan-Polania AH; Bjerkehagen B; Ohnstad HO; Namløs HM; Wang J; Kristiansen BE; Myklebost O
    Cancer Res; 2006 Sep; 66(18):8984-93. PubMed ID: 16982739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pfetin as a prognostic biomarker of gastrointestinal stromal tumors revealed by proteomics.
    Suehara Y; Kondo T; Seki K; Shibata T; Fujii K; Gotoh M; Hasegawa T; Shimada Y; Sasako M; Shimoda T; Kurosawa H; Beppu Y; Kawai A; Hirohashi S
    Clin Cancer Res; 2008 Mar; 14(6):1707-17. PubMed ID: 18347171
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
    Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
    J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pediatric KIT wild-type and platelet-derived growth factor receptor alpha-wild-type gastrointestinal stromal tumors share KIT activation but not mechanisms of genetic progression with adult gastrointestinal stromal tumors.
    Janeway KA; Liegl B; Harlow A; Le C; Perez-Atayde A; Kozakewich H; Corless CL; Heinrich MC; Fletcher JA
    Cancer Res; 2007 Oct; 67(19):9084-8. PubMed ID: 17909012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
    Liegl B; Hornick JL; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential expression of neural markers in KIT and PDGFRA wild-type gastrointestinal stromal tumours.
    Pantaleo MA; Astolfi A; Nannini M; Ceccarelli C; Formica S; Santini D; Heinrich MC; Corless C; Dei Tos AP; Paterini P; Catena F; Maleddu A; Saponara M; Di Battista M; Biasco G
    Histopathology; 2011 Dec; 59(6):1071-80. PubMed ID: 22175887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.
    Loughrey MB; Trivett M; Beshay V; Dobrovic A; Kovalenko S; Murray W; Lade S; Turner H; McArthur GA; Zalcberg J; Waring PM
    Histopathology; 2006 Jul; 49(1):52-65. PubMed ID: 16842246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Array comparative genomic hybridization analysis of chromosomal imbalances and their target genes in gastrointestinal stromal tumors.
    Assämäki R; Sarlomo-Rikala M; Lopez-Guerrero JA; Lasota J; Andersson LC; Llombart-Bosch A; Miettinen M; Knuutila S
    Genes Chromosomes Cancer; 2007 Jun; 46(6):564-76. PubMed ID: 17330260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct biphasic histomorphological pattern in gastrointestinal stromal tumours (GISTs) with common primary mutations but divergent molecular cytogenetic progression.
    Agaimy A; Haller F; Gunawan B; Wünsch PH; Füzesi L
    Histopathology; 2009 Feb; 54(3):295-302. PubMed ID: 19236505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deletion of the KIT gene is associated with liver metastasis and poor prognosis in patients with gastrointestinal stromal tumor in the stomach.
    Cho S; Kitadai Y; Yoshida S; Tanaka S; Yoshihara M; Yoshida K; Chayama K
    Int J Oncol; 2006 Jun; 28(6):1361-7. PubMed ID: 16685437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-KIT mutation analysis for diagnosis of gastrointestinal stromal tumors in fine needle aspiration specimens.
    Willmore-Payne C; Layfield LJ; Holden JA
    Cancer; 2005 Jun; 105(3):165-70. PubMed ID: 15822120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic analysis of patients with gastrointestinal stromal tumors: a single unit experience with surgical treatment of primary disease.
    Cao H; Zhang Y; Wang M; Shen DP; Sheng ZY; Ni XZ; Wu ZY; Liu Q; Shen YY; Song YY
    Chin Med J (Engl); 2010 Jan; 123(2):131-6. PubMed ID: 20137358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel correlation between LINE-1 hypomethylation and the malignancy of gastrointestinal stromal tumors.
    Igarashi S; Suzuki H; Niinuma T; Shimizu H; Nojima M; Iwaki H; Nobuoka T; Nishida T; Miyazaki Y; Takamaru H; Yamamoto E; Yamamoto H; Tokino T; Hasegawa T; Hirata K; Imai K; Toyota M; Shinomura Y
    Clin Cancer Res; 2010 Nov; 16(21):5114-23. PubMed ID: 20978145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect.
    Agaimy A; Dirnhofer S; Wünsch PH; Terracciano LM; Tornillo L; Bihl MP
    Am J Surg Pathol; 2008 Oct; 32(10):1553-9. PubMed ID: 18724245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic site.
    Antonescu CR; Viale A; Sarran L; Tschernyavsky SJ; Gonen M; Segal NH; Maki RG; Socci ND; DeMatteo RP; Besmer P
    Clin Cancer Res; 2004 May; 10(10):3282-90. PubMed ID: 15161681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal stromal tumors with KIT exon 11 deletions are associated with poor prognosis.
    Andersson J; Bümming P; Meis-Kindblom JM; Sihto H; Nupponen N; Joensuu H; Odén A; Gustavsson B; Kindblom LG; Nilsson B
    Gastroenterology; 2006 May; 130(6):1573-81. PubMed ID: 16697720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA sequence copy number changes in gastrointestinal stromal tumors: tumor progression and prognostic significance.
    El-Rifai W; Sarlomo-Rikala M; Andersson LC; Knuutila S; Miettinen M
    Cancer Res; 2000 Jul; 60(14):3899-903. PubMed ID: 10919666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integration of DNA copy number alterations and prognostic gene expression signatures in breast cancer patients.
    Horlings HM; Lai C; Nuyten DS; Halfwerk H; Kristel P; van Beers E; Joosse SA; Klijn C; Nederlof PM; Reinders MJ; Wessels LF; van de Vijver MJ
    Clin Cancer Res; 2010 Jan; 16(2):651-63. PubMed ID: 20068109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors.
    Schneider-Stock R; Boltze C; Lasota J; Miettinen M; Peters B; Pross M; Roessner A; Günther T
    J Clin Oncol; 2003 May; 21(9):1688-97. PubMed ID: 12721243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.